Table 1 Clinical characteristics of the patients
From: Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study
Characteristics N = 58 | Number | percentage |
|---|---|---|
Age,median (range): 53 (28–69) | ||
  < 50 | 16 | 27.6 |
 50–65 | 40 | 69.0 |
 ≥ 65 | 2 | 3.4 |
Gender | ||
 Male | 54 | 93.1 |
 Female | 4 | 6.9 |
ECOG performance status | ||
 0 | 37 | 63.8 |
 1 | 21 | 36.2 |
 2 | 0 | 0 |
Smoking | ||
 Yes | 49 | 84.5 |
 No | 9 | 15.5 |
Alcohol drinking | ||
 Yes | 44 | 75.9 |
 No | 14 | 24.1 |
Betal nut chewing | ||
 Yes | 43 | 74.1 |
 No | 15 | 25.9 |
Stage (AJCC 8th edition) | ||
 III (HPV+ oropharynx) | 6 | 10.3 |
 IVa | 13 | 22.4 |
 IVb | 39 | 67.3 |
T | ||
 1,2 | 13 | 22.4 |
 3 | 9 | 15.5 |
 4a | 13 | 22.4 |
 4b | 23 | 39.7 |
N | ||
 0 | 5 | 8.6 |
 2 (HPV+ oropharynx) | 3 | 5.2 |
 2b | 14 | 24.1 |
 2c | 11 | 19.0 |
 3 | 25 | 43.1 |
Site | ||
 Oral cavity | 18 | 31.0 |
 Oropharynx | 25 | 43.1 |
  HPV associated | 6 | 10.4 |
  HPV negative | 19 | 32.7 |
 Hypopharynx | 15 | 25.9 |
Neck dissection after ICT | ||
 Yes | 8 | 13.8 |
 No | 50 | 86.2 |